Management of Umbilical Hernia with Ascites
Initial Medical Management
- The American Association for the Study of Liver Diseases recommends aggressive medical control of ascites with sodium restriction (2000 mg/day) and diuretics (spironolactone up to 400 mg/day plus furosemide up to 160 mg/day) as the primary treatment strategy for umbilical hernia with ascites, combined with a multidisciplinary decision regarding timing of surgical repair based on liver transplant candidacy, MELD score, and presence of complications 1, 2
- Medical therapy for ascites control consists of sodium restriction to 88-90 mmol/day (approximately 2000 mg/day) 4, 1
- Spironolactone is started at 100 mg/day, titrating up to 400 mg/day, and furosemide is added if spironolactone alone fails, up to 160 mg/day 5, 4
- Large volume paracentesis (LVP) is performed for tense ascites, with albumin infusion (8 g/L removed if >5L) 6, 2
Critical Decision Point: Liver Transplant Candidacy
- If a patient is a liver transplant candidate, the American Association for the Study of Liver Diseases recommends deferring hernia repair until during or after liver transplantation 1, 8
- For patients who are not transplant candidates or have a low MELD score, elective herniorrhaphy should be considered after careful risk-benefit assessment, but only after ascites is controlled 1, 3
Surgical Technique and Timing
- The American Association for the Study of Liver Diseases recommends a laparoscopic approach for elective repair, which avoids skin incision and ascitic leak 1
- Prosthetic mesh may be used if ascites is sterile and controlled, but it increases infection risk 1
- For emergency repair with contamination, primary suture repair is preferred over mesh if bowel resection or contaminated field 7
Postoperative Management
- Postoperative management includes strict sodium restriction to 2000 mg/day (90 mmol/day), minimizing IV maintenance fluids, continuing diuretics to prevent ascites reaccumulation, and optimizing nutrition 1, 9